In women, testosterone is produced by the ovaries in small amounts; however, levels of testosterone decline with age, independent of menopausal status. Low-dose testosterone has been used to improve sexual functioning in women with [...]
The Food and Drug Administration (FDA) has approved a new drug for the treatment of hypoactive sexual desire disorder in premenopausal women. Bremelanotide (to be marketed as Vyleesi) is used on-demand. Bremelanotide is a peptide [...]
Dehydroepiandrosterone (DHEA) is a steroid hormone produced by humans. It functions as a metabolic intermediate in the biosynthesis of the androgen and estrogen sex steroids. In a recent study, presented at the annual meeting [...]
Hypoactive sexual desire disorder (HSDD) is the most common type of female sexual dysfunction, affecting approximately 10% of all adult women. In certain populations of women that we see in our clinic, including women [...]
